Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/17432

Registo completo
Campo DCValorIdioma
dc.contributor.authorTermini, Lara-
dc.contributor.authorFilho, A. L.-
dc.contributor.authorMaciag, Paulo Cesar-
dc.contributor.authorEtlinger, Daniela-
dc.contributor.authorAlves, Venâncio Avancini Ferreira-
dc.contributor.authorNonogaki, Suely-
dc.contributor.authorSoares, Fernando Augusto-
dc.contributor.authorVilla, Luisa Lina-
dc.date.accessioned2012-02-24T18:48:19Z-
dc.date.available2012-02-24T18:48:19Z-
dc.date.issued2011-07-
dc.identifier.issn0278-0240por
dc.identifier.urihttps://hdl.handle.net/1822/17432-
dc.descriptionWe are grateful to Carlos Ferreira do Nascimento and Severino Ferreira from the Hospital A.C. Camargo for technical assistance. We would like to thank Dr. Enrique Boccardo, Dr. Ismar Haga and Dr. Ana Paula Lepique for critical review of the manuscript and Dr. Erico Tosoni Costa for assistance in figure preparation.por
dc.description.abstractObjective: Superoxide dismutase-2 (SOD2) is considered one of the most important antioxidant enzymes that regulate cellular redox state in normal and tumorigenic cells. Overexpression of this enzyme may be involved in carcinogenesis, particularly in lung, gastric, colorectal and breast cancer. Methods: In the present study, we have evaluated SOD2 protein levels by immunohistochemistry (IHC) in 331 cervical histological samples including 31 low-grade cervical intraepithelial neoplasia (LSIL), 51 high-grade cervical intraepithelial neoplasia (HSIL), 197 squamous cervical carcinomas (SCC) and 52 cervical adenocarcinomas (ADENO). Results: We observed that SOD2 staining increases with cervical disease severity. Intense SOD2 staining was found in 13% of LSIL, 25.5% of HSIL and 40% of SCC. Moreover, 65.4% of ADENO exhibited intense SOD2 staining. Conclusions: Differences in the expression of SOD2 could potentially be used as a biomarker for the characterization of different stages of cervical disease.por
dc.description.sponsorshipDr. Lara Termini was a Post-Doctoral fellow from Fundação de Amparo à Pesquisa do Estado de São Paulo (grant 05/57274-9).por
dc.language.isoengpor
dc.publisherIOS Presspor
dc.rightsrestrictedAccesspor
dc.subjectHuman papillomaviruspor
dc.subjectTissue Microarraypor
dc.subjectBiomarkerpor
dc.subjectCervical Neoplasiapor
dc.subjectSuperoxide Dismutase-2por
dc.titleDeregulated expression of superoxide dismutase-2 correlates with different stages of cervical neoplasiapor
dc.typearticlepor
dc.peerreviewedyespor
dc.relation.publisherversionhttp://iospress.metapress.com/content/p719428q1x560042/por
sdum.publicationstatuspublishedpor
oaire.citationStartPage275por
oaire.citationEndPage281por
oaire.citationIssue6por
oaire.citationTitleDisease Markerspor
oaire.citationVolume30por
dc.identifier.doi10.3233/DMA-2011-0784por
dc.subject.wosScience & Technologypor
sdum.journalDisease Markerspor
Aparece nas coleções:ICVS - Artigos em revistas internacionais / Papers in international journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Termini L_Disease Markers 2011.pdf
Acesso restrito!
Documento principal968,68 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID